Pulmonary infections in patients with cystic fibrosis

Seminars in Respiratory Infections

Volumn 17, Issue 1, 2002, Pages 47-56

  Rajan, Sujatha ^a   Saiman, Lisa ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PIPERACILLIN; TIMENTIN; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BACTERIUM ISOLATION; CLINICAL FEATURE; CYSTIC FIBROSIS; DISEASE EXACERBATION; GENE THERAPY; HUMAN; INFECTION CONTROL; ION TRANSPORT; LUNG INFECTION; MAINTENANCE THERAPY; NUTRITIONAL SUPPORT; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS;

BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE SUSCEPTIBILITY; GENE THERAPY; GRAM-NEGATIVE AEROBIC RODS AND COCCI; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; NUTRITION PHYSIOLOGY; OPPORTUNISTIC INFECTIONS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0036125965     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2002.31690     Document Type: Article

References (40)

1. Cystic fibrosis: Pathogenesis, pulmonary infection, and treatment
2. Management of pulmonary disease in patients with cystic fibrosis
3. Identification of the cystic fibrosis gene: Genetic analysis
4. Cystic fibrosis and the salt controversy
5. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells
6. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator
7. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections
8. Lower airway inflammation in infants and young children with cystic fibrosis
9. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8
10. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is down-regulated in cystic fibrosis
11. The diagnosis of cystic fibrosis: A consensus statement
12. Microbiology of sputum from patients at cystic fibrosis centers in the United States
13. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years
14. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype
15. Bacterial biofilms: A common cause of persistent infections
16. Infection and immunity to Pseudomonas
17. Burkholderia cepacia infections in cystic fibrosis
18. Allergic bronchopulmonary Aspergillosis
19. Nontuberculous mycobacterial pulmonary disease in cystic fibrosis
20. Role of respiratory syncytial virus in early hospitalizations for respiratory distress in young infants with cystic fibrosis
21. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis
22. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period
23. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis
24. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs
25. Outcome measures for clinical trials in cystic fibrosis. Summary of a cystic fibrosis foundation consensus conference
26. Antibiotic pharmacokinetics in cystic fibrosis: Differences and clinical significance
27. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis
28. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
29. Consensus conference use of aerosolized antibiotics in patients with cystic fibrosis
30. Macrolides for the treatment of Pseudomonas aeruginosa infections?
31. Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis
32. Consensus conference: Practical applications of pulmozyme
33. A multicenter study of alternate day prednisone therapy in patients with cystic fibrosis
34. Effect of high-dose ibuprofen in patients with cystic fibrosis
35. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis
36. Nutritional benefits of neonatal screening for cystic fibrosis
37. Lung transplantation in cystic fibrosis: Consensus conference statement
38. Status of gene therapy for cystic fibrosis lung disease
39. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis
40. Infection control in cystic fibrosis: Practical recommendations for the hospital, clinic, and social settings